{"lastClose": 7.119999885559082, "len": 1092, "date": "2023-02-13", "alpha_1": -0.13401503775318002, "beta_1": 1.6589052404483535, "drawup_1": 1.5486725887776869, "natr_1": 12.434527445497839, "sup_1": -0.46161052288543813, "res_1": 0.3618914148013203, "bullPattern_1": [], "bearPattern_1": ["3OUTSIDE"], "rsi_1": 58.701297350166136, "adx_1": 41.338281433195654, "drawdown_1": -0.674768538064794, "stratHoldSharpe_1": -0.10741972999543015, "stratHoldAlpha_1": 250.9256289965138, "stratHoldDrawdown_1": -0.6334279201843875, "alpha_3mo": -0.7732318260958864, "beta_3mo": 2.0684544582796933, "drawup_3mo": 0.4608541290620036, "natr_3mo": 12.434527445497839, "sup_3mo": -0.1657303379565553, "res_3mo": 0.00983144029424965, "bullPattern_3mo": ["CLOSINGMARUBOZU", "ENGULFING", "LONGLINE"], "bearPattern_3mo": [], "rsi_3mo": 35.25179152742474, "adx_3mo": 32.62843852008713, "drawdown_3mo": -0.4781801627958294, "stratHoldSharpe_3mo": -1.5131650257512281, "stratHoldAlpha_3mo": 250.03621776403367, "stratHoldDrawdown_3mo": -0.4347214738441231, "Country": "United States", "Sector": "Health Care", "Market Cap": 1018123687, "Name": "Allogene Therapeutics Inc.", "Industry": "Biotechnology: Biological Products (No Diagnostic Substances)", "IPO Year": 2018.0, "alpha%_1": 0.4458572330953209, "beta%_1": 0.9062406329172374, "drawup%_1": 0.997782838384166, "natr%_1": 0.9998931250639753, "drawdown%_1": 0.07137138698831393, "stratHoldSharpe%_1": 0.3522167985686565, "stratHoldAlpha%_1": 0.3023345420678425, "stratHoldDrawdown%_1": 0.059626858269282705, "alpha%_3mo": 0.06753708218957422, "beta%_3mo": 0.9727215905995038, "drawup%_3mo": 0.8893485382379237, "natr%_3mo": 0.9998410666158131, "drawdown%_3mo": 3.346118453149804e-05, "stratHoldSharpe%_3mo": 0.05360625333151183, "stratHoldAlpha%_3mo": 0.006271120691881224, "stratHoldDrawdown%_3mo": 2.9455583858034933e-05}